NCT07434167Not yet recruiting
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 5 Feb 2026
- Start date
- Mar 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07434167
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Mar 2026 to the primary completion date, Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients requiring lobectomy.
- Patients who have not provided written informed consent.
- Vulnerable populations.
Who the study is looking for
- Patients aged between 18 and 80 who are scheduled to undergo lung nodule resection surgery.
- Patients with lung nodules smaller than 2 cm that require preoperative localization.
- Patients with lung nodules located in the outer one-third of the lung.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.